News
Amgen beat Q1 estimates with strong margins driven by Blincyto, Prolia, and standout Imdelltra growth, plus strength in ...
Two healthcare Dow stocks stunned investors with their sharp falls in May. The worst-performing Dow stock last month plunged ...
11h
Asianet Newsable on MSNJefferies Names Akero Therapeutics, Scholar Rock As Biotech Companies With Takeover Potential, But Retail Isn’t PleasedShares of Akero Therapeutics, Inc. (AKRO) jumped 3% on Friday afternoon after Jefferies said the company has a “promising” ...
The Clay County Sheriff's Office announced it has arrested more than 100 people and seized nearly 20,000 grams of illegal ...
Health Secretary Robert F. Kennedy Jr. named eight new members to the CDC’s Advisory Committee on Immunization Practices on ...
Despite a $258 million deficit, the city of San Diego still averages over $6K per day to maintain the vacant 101 Ash Street building.
Explore more
20h
Asianet Newsable on MSNMerck Gets FDA Approval For Keytruda To Treat A Broader Population Of Head And Neck Cancer Patients: Retail Stays BullishIn the U.S., it is estimated there will be approximately 72,680 new cases of head and neck cancer diagnosed and more than ...
Merck's Keytruda receives FDA approval for head and neck cancer after showing improved event-free survival in Phase 3 KEYNOTE ...
Sly & The Family Stone's "Family Affair" saw a splintering band reach the highest heights of pop music one last time.
Germany’s Merck KGaA has presented detailed results from cohort B of the global Phase II WILLOW study of enpatoran, an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results